iShares Genomics Immunology and Healthcare ETF (IDNA)
- Previous Close
19.32 - Open
19.44 - Bid 19.17 x 1000
- Ask 19.23 x 800
- Day's Range
19.25 - 19.66 - 52 Week Range
17.26 - 25.80 - Volume
4,493 - Avg. Volume
35,363 - Net Assets 111.77M
- NAV 19.32
- PE Ratio (TTM) 20.92
- Yield 1.06%
- YTD Daily Total Return -14.63%
- Beta (5Y Monthly) 1.14
- Expense Ratio (net) 0.47%
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
iShares
Fund Family
Health
Fund Category
111.77M
Net Assets
2019-06-11
Inception Date
Performance Overview: IDNA
View MoreTrailing returns as of 5/13/2025. Category is Health.
People Also Watch
Holdings: IDNA
View MoreTop 10 Holdings (50.74% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: IDNA
View MoreCyberArk Earnings: Firm's Business Remains Resilient Despite the Macro Headwinds
CyberArk is a cybersecurity vendor focused on the identity market. The company’s core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.
RatingPrice TargetClean Energy: House Tax Bill Broadly in Line With Our Expectations, but Better Than Many Feared
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
RatingPrice TargetLowering target price to $65.00
ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $65.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetEnphase Looks to New Geographies and Market Segments to Drive Continued Growth
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
RatingPrice Target